UHAC 62 XX

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UHAC 62 XX, covering 2014-07-08 to 2014-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers [Phase 1]